Mo Fei, Di Yu, Li Ying
Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
J Ophthalmol. 2022 Jul 11;2022:1640249. doi: 10.1155/2022/1640249. eCollection 2022.
To study the corneal morphology and biomechanics in cases of small incision lenticule extraction with prophylactic accelerated collagen cross-linking (SMILE Xtra).
This study was a retrospective study. 28 eyes of 14 patients with moderate-high risk of postoperative ectasia according to the Randleman scoring system underwent SMILE Xtra procedure. Outcome data were recorded including uncorrected distance visual acuity (UDVA), manifest refraction spherical equivalent (MRSE), surface regularity index (SRI), surface asymmetry index (SAI), simulated keratometry (SimK), posterior axial curvature (PAC), anterior and posterior corneal elevations (ACE and PCE), central corneal thickness (CCT), corneal resistance factor (CRF), corneal hysteresis (CH), and cornea-compensated intraocular pressure (IOPcc). The follow-up period was 12 months.
There were 28, 26, 22, 12, and 10 eyes enrolled at postoperative 1 day and 1, 3, 6, and 12 months, respectively. The UDVA improved from 1.27 ± 0.18 logMAR preoperatively to -0.06 ± 0.04 logMAR postoperatively ( < 0.05). The MRSE improved from -5.05 ± 1.15 preoperatively to -0.14 ± 0.30 postoperatively ( < 0.05). SAI, SimK, PAC, PCE, and CCT all changed significantly at 1 month postoperatively ( < 0.05) and stabilized during the remainder of the follow-up ( > 0.05). There was no significant change in SRI or ACE before and after surgery ( > 0.05). CRF, CH, and IOPcc all decreased significantly at 1 month postoperatively ( < 0.05) and remained stable afterwards ( > 0.05).
The changes in the corneal morphology and biomechanics remained stable after SMILE Xtra, and there was no sign of postoperative ectasia or refractive regression. Combined with the improvement of visual and refractive results, SMILE Xtra may be a promising method for corneal refractive surgeries in patients at risk.
研究采用预防性加速胶原交联的小切口透镜切除术(SMILE Xtra)病例的角膜形态和生物力学。
本研究为回顾性研究。根据兰德尔曼评分系统,对14例术后角膜扩张中高风险患者的28只眼进行了SMILE Xtra手术。记录结果数据,包括未矫正远视力(UDVA)、明显验光球镜等效度(MRSE)、表面规则性指数(SRI)、表面不对称指数(SAI)、模拟角膜曲率(SimK)、后轴曲率(PAC)、角膜前后高度(ACE和PCE)、中央角膜厚度(CCT)、角膜阻力因子(CRF)、角膜滞后(CH)和角膜补偿眼压(IOPcc)。随访期为12个月。
术后1天、1、3、6和12个月分别有28、26、22、12和10只眼纳入研究。UDVA从术前的1.27±0.18 logMAR提高到术后的 -0.06±0.04 logMAR(P<0.05)。MRSE从术前的 -5.05±1.15 D提高到术后的 -0.14±0.30 D(P<0.05)。SAI、SimK、PAC、PCE和CCT在术后1个月均有显著变化(P<0.05),并在随访的其余时间保持稳定(P>0.05)。手术前后SRI或ACE无显著变化(P>0.05)。CRF、CH和IOPcc在术后1个月均显著降低(P<0.05),此后保持稳定(P>0.05)。
SMILE Xtra术后角膜形态和生物力学变化保持稳定,无术后角膜扩张或屈光回退迹象。结合视力和屈光结果的改善,SMILE Xtra可能是一种有前景的针对有风险患者的角膜屈光手术方法。